Table 3: Injection practices in ‘pain-present’ and ‘pain-free’ subgroups of the study subjects.
Parameter | Total patients (N=847) | Pain present (n=473) | Pain free (n=374) | p* |
---|---|---|---|---|
Insulin device | ||||
Syringe | 68.1 | 73.2 | 61.8 | <0.001 |
Pen | 31.9 | 26.8 | 38.2 | |
Main site of injection | ||||
Abdomen | 63.6 | 60.3 | 67.9 | 0.022 |
Other than abdomen | 36.4 | 39.7 | 32.1 | |
Needle reuse | ||||
≤2 times | 1.7 | 1.1 | 2.5 | 0.001 |
3–5 times | 22.2 | 24.6 | 19.2 | |
6–10 times | 35.4 | 30.4 | 41.9 | |
>10times | 40.7 | 43.9 | 36.4 | |
Needle length | ||||
4 mm | 8.3 | 11.8 | 3.7 | <0.001 |
5 mm | 14.4 | 10.4 | 19.5 | |
6 mm | 31.8 | 26.4 | 38.5 | |
8 mm | 40.5 | 44.8 | 35.0 | |
12 mm | 5.1 | 6.6 | 3.2 | |
Injects into a skinfold | ||||
Yes | 89.7 | 90.1 | 89.3 | 0.401 |
No | 10.3 | 9.9 | 10.7 | |
Angle of needle entry | ||||
90 degrees | 64.6 | 59.8 | 70.6 | 0.001 |
Other than 90 degrees | 35.4 | 40.2 | 29.4 | |
Bleeding | ||||
Yes | 35.5 | 44.8 | 23.8 | <0.001 |
No | 64.5 | 55.2 | 76.2 |
Data are presented as % unless otherwise stated.
*p-value by Chi-square test.